Healthcare Data-as-a-Service Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Healthcare Data-as-a-Service Platforms
1.1 - About Healthcare Data-as-a-Service Platforms sector
Companies in the Healthcare Data-as-a-Service Platforms category aggregate, standardize, and deliver de-identified healthcare datasets via cloud feeds and APIs. They link claims, EHR, lab, pharmacy, and social determinants data, wrap access with HIPAA-aligned governance, and scale delivery for analytics and product teams. Analysts researching strategic buyers in healthcare data services look to these providers to power real-world evidence, market intelligence, risk modeling, and digital health applications.
Typical offerings include longitudinal patient datasets that stitch medical and pharmacy claims to EHR encounters, lab results, and registries through tokenization and identity resolution. Vendors provide FHIR and HL7 APIs, bulk data extracts, cohort builders, data normalization pipelines, and master provider directories with affiliations. Many add SDOH enrichment, privacy-preserving record linkage, consent management, and licensing models suited for research, commercial analytics, and embedded application use cases.
Primary customers include pharmaceutical and biotech companies, health plans and payers, and digital health platforms. These buyers seek faster time-to-insight, improved patient and provider targeting, higher-quality real-world evidence, and reduced data integration costs under strong compliance. Outcomes include more accurate risk adjustment, better care management, streamlined commercial analytics, and accelerated product development enabled by reliable, scalable access to linked healthcare data.
2. Buyers in the Healthcare Data-as-a-Service Platforms sector
2.1 Top strategic acquirers of Healthcare Data-as-a-Service Platforms companies
Human Longevity
HQ: United States
Website
- Description: Provider of AI-driven preventive healthcare services offering executive health programs that integrate whole genome sequencing, whole-body MRI (including prostate MRI), 100+ biomarker analyses, genomic risk assessment and long-term blood marker tracking to deliver personalized recommendations, early disease detection and a $1 million prostate cancer treatment support pledge.
- Key Products:
- Executive Health Program: Comprehensive half-day assessment combining whole genome sequencing, whole-body MRI, 100+ biomarker and cardiovascular analyses, producing 150 GB of data and AI-optimized recommendations for proactive longevity
- Prostate Cancer Screening Commitment: Integrated prostate MRI
- PSA monitoring and genomic analysis with a pledge of up to $1 million in treatment support for enrolled members diagnosed late-stage
- Genomic Risk Assessment: Full genome sequencing to reveal disease predispositions, informing personalized preventative protocols alongside imaging and biomarker data
- Long-Term Blood Marker Tracking: Continuous monitoring of over 100 biomarkers, including PSA, enabling longitudinal insights, early anomaly detection and guided clinical follow-ups.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Healthcare Data-as-a-Service Platforms sector
M&A buyer group 1: Clinical Data Repository
57 companies
View group →
Description: Companies in the Healthcare Clinical Data Repository Platforms category centralize patient records, images, and lab results across care settings. They provide cloud or on‑premises repositories, interoperability services, and clinical documentation tools that ingest, normalize, and securely exchange data. Strategic buyers in this space focus on data governance, compliance, and scalable access, enabling clinicians and operations teams to streamline workflows and support evidence‑based decision‑making.
ESO
- Type: N/A
- Employees: ●●●●●
- Description: Provider of data-driven SaaS solutions that leverage electronic health records, interoperability platforms, fire record management and clinical registries to help EMS agencies, fire departments, hospitals and government bodies improve community health, patient outcomes and first-responder well-being.
- Key Products:
- ESO Electronic Health Record (EHR): Industry-leading, next-generation ePCR capturing detailed EMS patient data and auto-generated narratives to streamline documentation, ensure compliance and improve clinical outcomes
- ESO Health Data Exchange (HDE): First-of-its-kind interoperability platform securely sharing healthcare data between EMS and hospital systems, enabling seamless information flow and coordinated patient care
- ESO Fire RMS: Modern fire Record Management System that records incidents, inspections and personnel data, giving departments actionable insights to enhance operational efficiency and safety
- ESO Patient Registry: Cloud software for trauma, burn and stroke registries, standardizing data collection, enabling benchmarking and supporting evidence-based quality improvement initiatives.
🔒
🔒
🔒
View all 57 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Healthcare Data-as-a-Service Platforms sector
3.1 - Buyout funds in the Healthcare Data-as-a-Service Platforms sector
2.2 - Strategic buyer groups for Healthcare Data-as-a-Service Platforms sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Healthcare Data-as-a-Service Platforms companies
4.2 - Public trading comparable groups for Healthcare Data-as-a-Service Platforms sector
Valuation benchmark group 1: Healthcare IT and Analytics Software
5 companies
View group →
Description: Companies in this trading comparable group are public healthcare IT and analytics software providers delivering clinical, operational, and financial systems to providers and life sciences organizations. Offerings span EHR/HIS platforms, practice management, revenue cycle and revenue integrity, data platforms, and clinical research solutions. They are grouped as comparables given predominantly recurring SaaS and enterprise licenses, data assets, enterprise healthcare focus, and services that drive adoption and measurable outcomes.
IQVIA Holdings
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, offering cloud-based applications, real-world evidence solutions, clinical trial management, strategic consulting, and patient engagement services to accelerate clinical development and improve healthcare outcomes.
- Key Products:
- Cloud-based Applications: Provides a range of cloud-based tools for healthcare data management and analytics
- Clinical Trial Management: Offers comprehensive clinical research services, including monitoring and decentralized trials
- Real-world Evidence Solutions: Generates data insights to inform healthcare decisions and improve patient outcomes
- Strategic Consulting: Delivers tailored consulting services for advanced analytics and commercial processes
- Patient Engagement Services: Enhances patient engagement through innovative health solutions and strategic support.
🔒
🔒
🔒
View all 5 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →